Volumen | 24.290 |
|
|||||
News | (1) | ||||||
Tageshoch | 2,45 | Niedrig Hoch |
|||||
Tagestief | 2,37 |
Name | Symbol | Markt | Aktientyp |
---|---|---|---|
Oramed Pharmaceuticals Inc | ORMP | NASDAQ | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
2,38 | 2,37 | 2,45 | 2,35 |
Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
---|---|---|---|---|---|
126 | 24.290 | US$ 2,41 | US$ 58.494 | - | 1,67 - 5,25 |
Letzte Trade | Typ | Menge | Kurs | Währung |
---|---|---|---|---|
16:00:24 | 1 | US$ 2,44 | USD |
Finanzwerte ORMP
Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
---|---|---|---|---|---|---|
98,06M | 40,52M | - | 1,63M | 5,53M | 0,14 | 17,74 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Oramed Pharmaceuticals
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
06.5.2024 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
19.3.2024 | 14:00 | GlobeNewswire Inc. | Scilex Holding Company Announces Repayment in Full of the.. |
06.3.2024 | 23:00 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
20.2.2024 | 14:42 | Edgar (US Regulatory) | Form 8-K - Current report |
20.2.2024 | 14:30 | PR Newswire (US) | Oramed Letter to Shareholders |
30.1.2024 | 23:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
23.1.2024 | 22:45 | Edgar (US Regulatory) | Form 8-K - Current report |
19.1.2024 | 22:45 | Edgar (US Regulatory) | Form 8-K - Current report |
08.1.2024 | 22:43 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
08.1.2024 | 22:41 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
08.1.2024 | 22:40 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
08.1.2024 | 22:39 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
Forum Oramed Pharmaceuticals
Keine Diskussionen Gefunden.Neuen Thread Erstellen
ORMP Historisch
Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
---|---|---|---|---|---|---|---|
1 Woche | 2,46 | 2,48 | 2,24 | 2,36 | 70.147 | -0,02 | -0,81% |
1 Monat | 2,64 | 2,81 | 2,14 | 2,41 | 94.455 | -0,20 | -7,58% |
3 Monate | 3,06 | 3,67 | 2,14 | 2,93 | 149.665 | -0,62 | -20,26% |
6 Monate | 1,80 | 3,67 | 1,80 | 2,58 | 169.730 | 0,64 | 35,56% |
1 Jahr | 2,84 | 5,25 | 1,67 | 3,19 | 333.027 | -0,40 | -14,08% |
3 Jahre | 10,99 | 31,54 | 1,67 | 8,48 | 697.127 | -8,55 | -77,80% |
5 Jahre | 3,60 | 31,54 | 1,67 | 8,03 | 524.515 | -1,16 | -32,22% |